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ABSTRACT
Inﬂuenza C virus, a member of the Orthomyxoviridae
family, causes ﬂu-like disease but typically only with mild
symptoms. Humans are the main reservoir of the virus,
but it also infects pigs and dogs. Very recently, inﬂuenza
C-like viruseswere isolated frompigs andcattle that differ
from classical inﬂuenza C virus and might constitute a
new inﬂuenza virus genus. Inﬂuenza C virus is unique
since it contains only one spike protein, the hemagglu-
tinin-esterase-fusion glycoprotein HEF that possesses
receptor binding, receptor destroying and membrane
fusion activities, thus combining the functions of
Hemagglutinin (HA) and Neuraminidase (NA) of inﬂuenza
A and B viruses. Here we brieﬂy review the epidemiology
and pathology of the virus and the morphology of virus
particles and their genome. The main focus is on the
structure of the HEF protein aswell as on its co- and post-
translational modiﬁcation, such as N-glycosylation,
disulﬁde bond formation, S-acylation and proteolytic
cleavage into HEF1 and HEF2 subunits. Finally, we
describe the functions of HEF: receptor binding, esterase
activity and membrane fusion.
KEYWORDS inﬂuenza C virus, HEF, structure, receptor
binding, esterase, membrane fusion
INTRODUCTION
Inﬂuenza C virus was ﬁrst isolated during an epidemic of
respiratory illness in 1947. Since the virus showed no cross
reactivity with antisera against inﬂuenzaAandBviruses it was
classiﬁed as a new genus of the Orthomyxoviridae, named
inﬂuenza C virus (Francis et al., 1950; Taylor, 1949, 1951).
Inﬂuenza C virus usually causes inﬂammation of the upper
respiratory tract, especially in children from two to six years of
age. Clinical symptoms, such as cough, fever, malaise are
typically mild. Only occasionally the virus spreads to the lower
respiratory tract and causes bronchitis, bronchiectasie and
broncho-pneumonia (Gouarin et al., 2008; Kauppila et al.,
2014; Matsuzaki et al., 2007; Matsuzaki et al., 2006; Muraki
andHongo, 2010). Although inﬂuenzaC virus infections occur
primarily in a pattern of sporadic cases or in limited outbreaks
(Joosting et al., 1968; Minuse et al., 1954), serological studies
indicated that this virus is widely distributed around the world
and that the majority of humans develope antibodies against
the virus early in life (Matsuzaki et al., 2006; Salez et al., 2014).
In a serological study carried out in France, 60%–70% of the
population was found to be previously exposed to the virus,
the highest rates of positive samples was found in the 16–30
years age group (Manuguerra et al., 1992). In a 6-year
tracking study in hospitalized children in Spain, inﬂuenza C
infections accounted for 13% of inﬂuenza-positive cases
(Calvo et al., 2013). The results indicate intense circulation of
inﬂuenza C virus in the human population.
The primary host and reservoir of inﬂuenza C virus are
humans, but there is evidence that this virus possesses the
ability to also infect animals (Muraki and Hongo, 2010).
Serological studies showed that antibodies against inﬂuenza
C virus are widely present in dogs and especially in pigs
(Brown et al., 1995; Horimoto et al., 2014; Manuguerra and
Hannoun, 1992; Manuguerra et al., 1993; Ohwada et al.,
1987; Yamaoka et al., 1991; Youzbashi et al., 1996). In 1981,
a number of inﬂuenza C virus strains were isolated from pigs
in Beijing and these strains could be transmitted from pig to
pig under experimental conditions (Guo et al., 1983).
In 2011, an inﬂuenza C-like virus was isolated from clini-
cally ill pigs exhibiting inﬂuenza-like symptoms (C/Oklahoma/
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1334/2011) and also from cattle (D/bovine/Oklahoma/660/
2013) which subsequently turned out to be the main reservoir
of this newly discovered virus (Collin et al., 2014, 2015; Hause
et al., 2013). Phylogenetic analysis showed that these strains
have only 50% overall amino acid homology to human inﬂu-
enza C viruses, a divergence similar to that described
between inﬂuenza A and B viruses (Hause et al., 2013).
Accordingly, no cross reactivity was observed between these
strains and human inﬂuenza C virus antisera. This new strain
has a broader cell tropism than human inﬂuenzaC virus and is
capable of infecting and transmitting by direct contact in both
pigs and ferrets. It also encodes a novel mechanism for gen-
erating the M1 protein and, importantly, is unable to reassort
with human inﬂuenza C virus and generate viable progeny.
Based on these differences to inﬂuenza C virus it was sug-
gested that this viruswarrants classiﬁcation as a newgenus of
inﬂuenza virus, named inﬂuenza D virus (Collin et al., 2014;
Hause et al., 2013).
VIRAL PARTICLE AND GENOME STRUCTURE OF
INFLUENZA C VIRUS
Inﬂuenza C virus particles exhibit two morphologies, either
spherical with a diameter of 80–120 nm or ﬁlamentous with
the same diameter but with lengths in µm range (Waterson
et al., 1963). Already during the budding process at the
plasma membrane, ﬁlamentous particles may aggregate via
their long axes into 500 μm long cord-like structures, which
are all covered by a layer of surface projections (Nishimura
et al., 1990). Studies using reverse genetics showed that an
amino acid exchange at residue 24 of the M1 protein (Ala to
Thr) that reduces membrane association of this intrinsically
hydrophobic protein eliminates cord formation and also
affects virus morphology (Muraki et al., 2004; Nishimura
et al., 1994). Another unique characteristic of inﬂuenza C
virus particles observed by electron microscopy is a reticular
hexagonal structure, which is formed by the HEF protein and
discussed in more detail below (Apostolov and Flewett,
1969; Flewett and Apostolov, 1967; Herrler et al., 1981).
The inﬂuenza C virus genome consists of negative-sense,
single-stranded RNA (Desselberger et al., 1980), but in
contrast to inﬂuenza A and B virus only seven (not eight)
gene segments are present in virus particles (see Fig. 1 for
the structure of a virus particle and Fig. 2 for the structure of
viral genome segments). The longest three segments
encode the proteins PB2, PB1 and P3 that form the het-
erotrimeric polymerase complex (Yamashita et al., 1989).
The protein encoded by the third segment is named P3
(instead of PA as in the case of inﬂuenza A virus) since it
does not contain negative charges at neutral pH. The fourth
segment encodes the glycoprotein HEF, the only spike of the
viral membrane (Herrler et al., 1988a). The ﬁfth segment
encodes the nucleoprotein NP that associates with the viral
genome segments along its whole length and builds, toge-
ther with the polymerases the viral ribonucleoprotein com-
plex (vRNPs) (Nakada et al., 1984b). The sixth segment
encodes two proteins, the matrix protein M1, a peripheral
membrane protein that covers the viral envelope on its
inside, and CM2, a short transmembrane protein supposed
to exhibit proton-channel activity required for dissociation of
ribonucleoprotein (RNP) complexes from M1 and thus
release of uncoated RNPs into the cytoplasm where they are
imported into the nucleus to start viral replication. M1 and
CM2 are generated by alternative splicing, but in a different
manner as described for inﬂuenza A virus. Whereas in
inﬂuenza A virus M1 is translated from a unspliced mRNA,
M1 of inﬂuenza C virus is generated from a spliced mRNA.
Removal of an intron generates the stop codon UGA such
that a protein containing 242 residues is translated (Ya-
mashita et al., 1988). The unspliced mRNA encoding CM2
translates into a long precursor protein (374 residues),
named p42. P42 contains an internal signal peptide (resi-
dues 239–259) which co-translationally targets the protein
from the cytosol to the ER and presents it to the translocon.
Here residues C-terminal to the signal peptide are translo-
cated into the lumen of the ER until translocation is stopped
by a second hydrophobic region (residues 285–308) that
functions as the transmembrane region (TMR) of CM2. The
signal peptide is then cleaved by signal peptidase yielding
the CM2 protein (115 residues) and the p31 protein (259
residues). P31, which is identical in sequence to M1 (except
the 18 C-terminal amino acids), is rapidly degraded after
cleavage from p42 suggesting that it does not plays any
functional role for the viral life cycle (Hongo et al., 1999;
Pekosz and Lamb, 1998). Whether CM2 is a proton channel
has not been directly demonstrated by biophysical assays,
but it alters the intracellular pH in transfected cells and its
transmembrane domain can substitute for that of the inﬂu-
enza A virus M2 protein (Stewart and Pekosz, 2012). The
seventh vRNA encodes the two non-structural proteins NS1
and NS2 that are also generated via mRNA splicing (Nakada
et al., 1985; Nakada et al., 1986). The unspliced mRNA is
translated into the NS1 protein (246 residues) and the
spliced mRNA translates the shorter NS2 protein (182 resi-
dues). The N-terminal 62 residues of NS1 and NS2 are
identical in sequence, splicing then generates a shift in the
ORF such that the remaining residues are translated from a
different reading frame (Alamgir et al., 2000).
All ORFs are ﬂanked by non-coding (NC) sequences,
which are more variable in length than those of inﬂuenza A
and B virus (Crescenzo-Chaigne et al., 2008). Non-coding
sequences are divided into conserved and non-conserved
sequences. The ﬁrst twelve nucleotides at each 3′ end
(3′-UCGUU/CUUCGUCC-5′) as well as the last eleven
nucleotides at each 5′ end (5′-AGCAGUAGCAA-3′) are
conserved between genome segments (Desselberger et al.,
1980; Robertson, 1979) and are partially complementary to
each other, which enables the single stranded RNA to form a
“panhandle” structure (Cheong et al., 1999; Desselberger
et al., 1980). This peculiar structure serves as the promotor
for transcription of cRNAs and vRNAs, and is required for the
endonuclease activity of the viral polymerase complex





























Figure 1. Scheme of inﬂuenza C virus and inﬂuenza A/B virus particles. Proteins having the same function are depicted with the
same symbol. Note that inﬂuenza C virus has only one spike protein, the hemagglutinin-esterase-fusion glycoprotein HEF that
combines the functions of both hemagglutinin (HA) and neuraminidase (NA) from inﬂuenza A and B virus. PB1, PB2, P3 and PB1,
PB2, PA are the polymerase proteins of inﬂuenza C virus and inﬂuenza A/B virus, respectively, that build together with the
nucleoprotein NP and the viral RNA-segments the ribonucleoprotein complexes (vRNP). M1 is the matrix protein and M2 and CM2
the proton-channel.
3′- UCGUUUUCGUCC -  - AACGAUGACGA - 5′PB2     (ORF)    774 aa - UUUUUU -
3′- UCGUUUUCGUCC -  - AACGAUGACGA - 5′PB1     (ORF)    754 aa - UUUUUU -
3′- UCGUUUUCGUCC -  - AACGAUGACGA - 5′P3     (ORF)    709 aa - UUUUUU -
3′- UCGUUUUCGUCC -  - AACGAUGACGA - 5′HEF     (ORF)    655 aa - UUUUUU -
3′- UCGUCUUCGUCC -  - AACGAUGACGA - 5′NP    (ORF)    565 aa - UUUUUU -
3′- UCGUCUUCGUCC -  - AACGAUGACGA - 5′M1 (ORF)  242 aa - UUUUUU -UG AIntron
Termination codon
Precursor P42 (ORF) 374 aa
CM2   115 aaRemoved   259 aa
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Figure 2. Structure of the seven inﬂuenza C virus genome segments. Open reading frames (ORFs) are indicated in black.
Segment six and seven encode two proteins which are generated by splicing. Inﬂuenza C virus possesses 7 minus-senses, single-
strand and segmented RNA. Each segment possesses 12 conserved nucleotides at 3′ terminal and 11 conserved nucleotides at
5′ terminal. A poly U motif is close to 5′ terminal and it transcripts into mRNA poly A tail. Each of the longest 5 segments possesses
only 1 open-reading-frame (ORF) and encodes PB2, PB1, P3, HEF and NP, respectively.
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(Crescenzo-Chaigne et al., 2008; Fodor et al., 1994; Hsu
et al., 1987). A uridine-rich region located at position 17 to 22
at the 5′ end of each segment is the template for the poly A
tail present at the 3′ end of each mRNA (Desselberger et al.,
1980).
HEF PROTEIN OF INFLUENZA C VIRUS
While inﬂuenza A and B virus contain the two glycoproteins
Hemagglutinin (HA) and Neuraminidase (NA) inserted into
the viral membrane, inﬂuenza C virus possesses only one
spike designated Hemagglutinin-Esterase-Fusion (HEF)
protein which combines the functions of both HA and NA
(Herrler et al., 1988a; Herrler and Klenk, 1991). Like HA, it
recognizes and binds to a receptor on the cell surface to
initiate virus entry. However, the receptor determinant is not
N-acetyl-neuraminic acid, but another derivative of neu-
raminic acid, namely N-acetyl-9-O-acetylneuraminic acid
(Rogers et al., 1986). HEF also catalyzes fusion of the viral
envelope with endocytic vesicles by a mechanism that is
believed to be similar to the well characterized fusion activity
of HA. Finally, HEF is the receptor-destroying enzyme, which
is the function of the neuraminidase (NA) in inﬂuenza A and
B virus. HEF does not cleave the terminal sialic acid residue
from carbohydrates, but has an esterase activity that
removes the acetyl group from position C-9 of N-acetyl-9-O-
acetylneuraminic acid (Herrler et al., 1985). This function is
probably required to release freshly budded virus particles
from infected cells, which would otherwise be trapped at their
plasma membrane if the receptor would still be present.
Interestingly, HEF can substitute for both HA and NA to
support inﬂuenza A virus replication if its gene is equipped
with the packaging signals from inﬂuenza A virus (Gao et al.,
2008). After a description of the structure and the modiﬁca-
tions of HEF its three functional activities will be discussed in
more detail below.
PRIMARY STRUCTURE OF THE HEF PROTEIN
All full-length HEF protein sequences present in the inﬂu-
enza virus database (http://www.ncbi.nlm.nih.gov/genomes/
FLU/Database/nph-select.cgi) contain 641 amino acids (aa,
excluding signal peptide), except HEF from one strain which
is one amino acid shorter. HEF (like HA) is a typical type 1
transmembrane protein with a short N-terminal, cleavable
signal peptide (14 amino acids), a long ectodomain (612 aa),
a transmembrane region (26 aa) and a very short cytoplas-
mic tail (three aa). HEF present in infectious virus particles is
composed of two subunits, the N-terminal 432 amino acids
are the HEF1 polypeptide, the remaining sequence including
the hydrophobic fusion peptide, the transmembrane domain
(TMD) and the cytoplasmic tail is called HEF2 (Nakada et al.,
1984a; Pfeifer and Compans, 1984). HEF proteins of the
novel inﬂuenza C-like viruses (inﬂuenza D virus) contain a
very similar number of amino acids (664 including signal
peptide) as HEF from inﬂuenza C virus, are predicted to also
adopt a type I membrane topology, but the amino acid
identity with HEF is only ∼53% (Hause et al., 2013).
According to a phylogenetic analysis of their HEF genes
the existing strains are divided into six genetic and antigenic
lineages, Taylor/1233/47, Aichi/1/81, Sao Paulo/378/82,
Kanagawa/1/76, Yamagata/26/81 and Mississippi/80 (Mat-
suzaki et al., 2003; Muraki and Hongo, 2010; Muraki et al.,
1996; Speranskaia et al., 2012). However, there is very little
sequence variation (Table S1) and thus inﬂuenza C virus
was considered to be monosubtypic and stable in evolution,
but reassortment between strains within the inﬂuenza C
genus occur frequently which leads to the appearance of
new strains better adapted to their host (Matsuzaki et al.,
2003; Peng et al., 1994).
We aligned the HEF sequences from the six inﬂuenza C
virus lineages to reveal amino acid identity and other com-
mon characteristics (Table S1). All residues important for the
structure of HEF, such as glycosylation sites, cysteine resi-
dues (with one exception, Cys 332 in the Taylor lineage,
numbering of HEF excluding the signal peptide), the N-ter-
minal region of HEF2 containing the hydrophobic fusion
peptide and the amino acids of the receptor-binding and
receptor destroying domain of HEF are invariant. In general
(and in contrast to the highly variable HA proteins of inﬂu-
enza A and B virus), only a few amino acid residues are not
conserved through all lineages of HEF. 35 of them are
located in HEF1 and seven in the smaller subunit HEF2.
There are three small regions in HEF1 where many of the
variable amino acids are clustered; residues 61–65 contain
four amino acid substitutions, residue 165–172 six exchan-
ges and residues 190–195 ﬁve substitutions (Table S1). In
the crystal structure of HEF the variable regions are located
in loops at the surface of the trimer; residue 165–172 and
190–195 near the receptor binding site at the top of the
molecule and residues 61–65 near the esterase domain
(Fig. 4). These amino acids have been shown to be antibody
epitopes that gradually change due to antigenic drift (Mat-
suzaki et al., 1992).
CRYSTAL STRUCTURE OF THE HEF PROTEIN
Initial studies using electron microscopy showed that the
HEF spike forms a mushroom-shaped trimer consisting of a
membrane-near stalk and a globular head (Herrler et al.,
1981; Hewat et al., 1984). X-ray crystallography of the
bromelain-cleaved ectodomain of HEF then revealed the
high resolution structure (4.5 Å) of the HEF trimer. Although
there is only 12% amino acid identity between HA and HEF,
the overall structure of both molecules as well as folds of
individual segments are quite similar, except an additional
bulge, which is located at the lower part of the globular
domain and contains the esterase region that is not present
in HA (Fig. 3). Similar to HA, the receptor-binding region is
located at the top of the head domain, which consists only of
HEF1 residues. The stalk is formed by three 60 Å long α-
helices that contain the whole HEF2 sequence and
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N-terminal residues 1–40 and C-terminal residues 367–432
of HEF1. The fusion peptide at the N-terminus of HEF2 is
located around 35 Å above the membrane, but in contrast to
HA, the ﬁrst four residues are exposed at its surface and not
buried within the trimer (Rosenthal et al., 1998; Zhang et al.,
1999). The detailed structure of the receptor binding site and
the catalytic center of the esterase activity will be discussed
in more detail in the last paragraph.
CO- AND POST-TRANSLATIONAL MODIFICATIONS
OF HEF
HEF is synthesized on membrane-bound ribosomes and the
primary translation product is subjected to a series of co- and
post-translational modiﬁcations, most of them are required
for proper folding and/or functioning. Already during
translocation of HEF into the lumen of the ER the N-terminal
signal peptide is cleaved, carbohydrates are attached and
intramolecular disulﬁde linkages are formed and probably
remodeled. These co-translational modiﬁcations affect fold-
ing of the molecule and its trimerization, processes which are
(at least in HA and other viral glycoproteins) a prerequisite
for exit of cargo from the ER (Doms et al., 1993). Later on a
long chain fatty acid is attached to a cysteine located at the
end of the transmembrane region and HEF is proteolytically
cleaved into the subunits HEF1 and HEF2, a process that is
essential for virus replication. Timing of both modiﬁcations
has not been analyzed for HEF, but in HA palmitoylation
occurs prior to proteolytic cleavage (Veit and Schmidt, 1993).
LOCATION OF N-GLYCOSYLATION SITES IN THE
CRYSTAL STRUCTURE OF HEF
HEF, like HA, contains only asparagine-linked carbohy-
drates; O-glycosylation does not occur (Herrler and Klenk,
1991; Hongo et al., 1986a). The composition of the carbo-
hydrate chains has not been precisely determined, but
apparently, some of them are not terminally glycosylated
since they are not processed to an Endo-H resistant form
(Pekosz and Lamb, 1999). The location of the individual
glycosylation sites in the crystal structure of HEF is depicted
in Fig. 4. Seven of the eight highly conserved N-glycosyla-
tion sequons (Asn-X-Ser/Thr) are used. One is located in
HEF2 and six in HEF1, three in the globular head and two in
the hinge region that connects the stalk with the head. The
site at position 589 is not glycosylated, probably because it is
located too close to the membrane-spanning region and
cannot be accessed by the oligosaccharide transferase
(Herrler and Klenk, 1991; Nakada et al., 1984a; Pfeifer and
Compans, 1984) (Fig. 4 and supplementary table). Although
the position of carbohydrates attached to HA of inﬂuenza A
virus changes and their number increases during viral
Esterase domain
Fusion peptide Influenza C HEF
Receptor binding site 
Influenza A HA
Figure 3. Comparison of the crystal structure of inﬂuenza C virus HEF protein and inﬂuenza A virus HA protein. Only the
ectodomains of both proteins were amenable for crystallization. The viral membrane is located beneath the structure. Individual
subunits of the trimeric spike proteins are drawn in different colors. The overall structure of both proteins is similar except an additional
bulge in the head domain of HEF that contains the esterase activity which is not present in HA. The receptor binding region, esterase
domain and the fusion peptide of HEF are enlarged. Figures were created with PyMol from PDB ﬁles 1RUZ (HA from inﬂuenza A virus
strain A/South Carolina/1/1918 (H1N1)) and 1FLC (HEF from inﬂuenza C virus strain C/Jhb/1/66 strain). HEF1 and HEF2 subunits of
one monomer are drawn in red and green, respectively. The other two monomers are labelled in yellow and blue, respectively.
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evolution (Skehel and Wiley, 2000), their distribution is quite
similar to that of HEF, i.e. the majority is located in the larger
subunit. Glycosylation of HEF is crucial for proper folding of
the glycoprotein by protecting it from proteolytic degradation
and hence important for the presentation of antigenic epi-
topes (Hongo et al., 1986b).
LOCATION OF INTRAMOLECULAR DISULFIDE
BONDS IN THE CRYSTAL STRUCTURE OF HEF
There are 15 cysteine residues in HEF1, twelve of them form
six intrachain disulﬁde linkages that stabilize the globular
head domain. Their location is depicted in the crystal struc-
ture of HEF in Fig. 5. Cysteine 332 is not required for proper
folding and functioning of HEF since it is exchanged by a
tyrosine in the Taylor lineage of inﬂuenza C virus. Two
cysteines, Cys373 and Cys399 that do not form a disulﬁde
linkage in the mature protein are located at the hinge that
connects the globular head with the stalk region. The
remaining cysteine in HEF1 forms an interchain disulﬁde
bond with the only cysteine residue in the ectodomain of
HEF2, which is located at the bottom of the trimer. A similar
distribution of disulﬁde bonds is present in HA of inﬂuenza A
virus, i.e. one disulﬁde bond connects HA1 with HA2; the
majority are intrachain bonds, three or four in HA1 and just
one in HA2 (Segal et al., 1992; Skehel and Wiley, 2000). The
rare occurrence of disulﬁde-bonds in HEF2 and HA2 allows
this subunit to perform the large conformational changes that
catalyze membrane fusion.
FOLDING AND INTRACELLULAR TRANSPORT
OF HEF
HEF (at least from the strain C/JHB/1/66) is subject of a
complicated folding procedure involving the formation and
remodeling of intramolecular disulﬁde bond (Szepanski
et al., 1994). In virus-infected cells freshly synthesized HEF
has an apparent molecular weight (MW) of 80 kDa as
demonstrated by both reducing and non-reducing SDS-
PAGE. This corresponds to the predicted molecular weight
of the glycosylated form of the protein (Sugawara et al.,
1981). Subsequently HEF is converted to a form with a MW
of 100 kDa, which appears after non-reducing, but not after
reducing SDS-PAGE, indicating that intramolecular disulﬁde-
bond formation causes the decrease in electrophoretic
mobility (Herrler et al., 1981). Besides reduction of disulﬁde
bonds, proteolytic cleavage also converts the 100 kDa into
the 80 kDa form suggesting that the 100 kDa form pos-
sesses a strained conformation (Herrler et al., 1979;
Szepanski et al., 1994).
When HEF from C/JHB/1/66 was expressed from cDNA
in the absence of the other viral proteins, conversion into the
100 kDa form was either very inefﬁcient or not observed at
all suggesting that the interaction of HEF with other viral
proteins is required for folding (Szepanski et al., 1994).
Expressed HEF is not transported to the cell surface, which
is in line with the established paradigm that proper folding is
a prerequisite for exit of proteins from the ER and hence
transport to the plasma membrane (Doms et al., 1993). The
defect in disulﬁde bond formation and surface transport was
partially overcome by either deleting its short cytoplasmic tail
(Arg-Thr-Lys), replacing it by the longer cytoplasmic tail of
inﬂuenza A virus HA or exchanging the two basic amino
acids to acidic or hydrophobic residues (Oeffner et al., 1999;
Szepanski et al., 1994).
In contrast, HEF proteins from the strains C/California/78,
C/Ann Arbor/1/50 and C/Taylor/1233/47 were efﬁciently
transported to the plasma membrane in the absence of other
viral proteins (Pekosz and Lamb, 1999; Vlasak et al., 1987).
In addition, conversion of an 80 kDa to a 100 kDa band was
not obvious by SDS-PAGE, although heterogeneity of bands



















Figure 4. Location of N-Glycosylation sites and variable
regions in the crystal structure of HEF. Asparagine residues
of used and unused glycosylation sequons (Asn-X-Ser/Thr) are
depicted in the secondary structure of a HEF monomer as
highlighted as balls. Amino acids in the HEF protein from
C/JHB/1/66, which vary in other inﬂuenza C virus isolates are
marked as sticks (Table S1). Threonine residue 270, which is
exchanged by isoleucine in a virus variant that has acquired the
ability to grow in MDCKII cells, is also marked as sticks. (This
residues is termed Thr284 in the publication (Szepanski et al.,
1992) since the 14 amino acid long signal peptide was included
in the numbering). Figure was created with PyMol from PDB ﬁle
1FLC. HEF1 and HEF2 subunits are drawn in red and green,
respectively.










HEF of Flu C REVIEW
disulﬁde bonds also occurs (Pekosz and Lamb, 1999). The
reason for this strikingly different behavior of HEF proteins is
unknown, but either subtle amino acid differences between
HEF proteins of different virus strains or between the cloned
HEF-gene and the gene present in virus particles of C/JHB/
1/66 have been discussed (Pekosz and Lamb, 1999).
There are also other indications that folding of HEF is
more complicated than folding of HA. Whereas HAs from
several inﬂuenza A virus strains have passed the medial-
Golgi (determined as acquisition of Endo-H resistant carbo-
hydrates), around 15 min after synthesis and are rapidly (t1/2:
30 min) and completely transported to the cell surface (Engel
et al., 2012), intracellular transport of HEF is slow and
incomplete. Half times of more than 60 min for acquisition of
Endo-H resistant carbohydrates and for transport to the
plasma membrane have been reported and only a fraction
(70%) of all synthesized molecules appear at the cell surface
(Pekosz and Lamb, 1999).
In addition, HEF exhibits intrinsic temperature sensitivity.
Expression levels of HEF at the plasma membrane are two
times higher at 33°C compared to 37°C and, probably as a
consequence, membrane fusion is more efﬁcient at 33°C
than at 37°C. Since trimerization of HEF is also reduced at
37°C the underlying cause of reduced cell surface exposure
is slower and less efﬁcient folding of HEF at higher tem-
peratures (Takashita et al., 2012) which is reminiscent of
temperature sensitive mutants of HA of inﬂuenza A virus
(Garten et al., 1992).
The temperature sensitivity of HEF is probably an adap-
tion of the virus to replicate only in the upper respiratory tract
that has, due to contact with inhaled air before it is warmed
up, a lower temperature than the lower respiratory tract. In
the lab (cell culture and chicken embryos) inﬂuenza C virus
is also ampliﬁed at 33°C where it grows to higher titers than
at 37°C (Crescenzo-Chaigne and van der Werf, 2007;
O’Callaghan et al., 1977; Pachler et al., 2010; Wagaman
et al., 1989). However, other proteins also inﬂuence the
temperature preference for virus replication since the poly-
merase also exhibits a higher activity at 33°C than at 37°C
(Nagele and Meier-Ewert, 1984).
S-ACYLATION AND RAFT-LOCALIZATION OF HEF
Another common modiﬁcation of viral glycoproteins is the
covalent attachment of fatty acids, usually palmitate (C 16:0)
in a thioester-type linkage to cysteine residues located either
at the cytosol-facing end of the transmembrane region or in
the cytoplasmic tail (Veit, 2012; Veit et al., 2013). HEF of
inﬂuenza C virus is unique in this aspect, since it contains
mainly stearic acid linked to cysteine 652 (Veit et al., 1990;
Veit et al., 1996) (Fig. 6). This longer chain fatty acid (C 18:0)
was initially identiﬁed by chromatographic determination of
HEF-bound, [3H]-labelled fatty acids, but results were
recently conﬁrmed by mass-spectrometry with C-terminal
anchoring fragments of HEF puriﬁed from virus particles
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Figure 5. Location of intramolecular disulﬁde linkages in HEF. The middle part shows the secondary structure of a HEF
monomer. HEF1 and HEF2 subunits are drawn in red and green, respectively. The left part shows the head domain which contains six
disulﬁde linkages and also two free cysteines. The right part shows the location of the only disulﬁde linkage between HEF1 and HEF2.
The ﬁgure was created with PyMol from PDB ﬁle 1FLC. HEF1 and HEF2 subunits are drawn in red and green, respectively.
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inﬂuenza B virus HA possessing two cytoplasmic cysteines
contains only palmitate, whereas HAs of inﬂuenza A virus
having one transmembrane and two cytoplasmic cysteines
contain both palmitate and stearate, but the latter is exclu-
sively attached to the cysteine positioned in the transmem-
brane region (Kordyukova et al., 2008; Naeve and Williams,
1990; Naim et al., 1992; Steinhauer et al., 1991; Veit et al.,
1990; Veit et al., 1991) (Fig. 6). It was originally proposed
that the different length of the cytoplasmic tails of HA (11 aa)
and HEF (3 aa) could be the reason for different fatty acid
selection (Veit et al., 1996), but a recent comprehensive
mutagenesis study with HA revealed that the location of a
cysteine relative to the transmembrane region is the decisive
factor for selective attachment of stearate (Brett et al., 2014).
Enzymes that attach palmitate and stearate to HA or HEF (or
to other viral glycoproteins) have not been identiﬁed so far,
but likely candidates are members of the family of DHHC-
proteins, polytopic membrane proteins with the Glu-His-His-
Cys motif in one of their cytoplasmic loops, that are known to
acylate cellular proteins (Greaves and Chamberlain, 2011).
Acylation of HA of inﬂuenza A virus is essential for virus
replication, since (depending on the virus strain) either virus
mutants with more than one acylation site deleted show
drastically impaired growth or could not be created at all by
reverse genetics (Chen et al., 2005; Wagner et al., 2005;
Zurcher et al., 1994). Recombinant virus lacking the acyla-
tion site of HEF could be rescued, but viral titers were
reduced by one log relative to wild type Flu C (our unpub-
lished results). The resulting virus particles have a regular
protein composition and no changes in their morphology
were obvious by electron microscopy, but their hemolytic
activity is reduced indicating a defect in membrane fusion.
This is in accordance with results on several HA subtypes
showing that (i) the stearoylated cysteine at the end of the
transmembrane span is less important for virus replication
compared to the two cytoplasmic palmitoylated cysteines
and that (ii) acylation affects opening of a fusion pore (Sakai
et al., 2002; Ujike et al., 2004; Wagner et al., 2005). How-
ever, for H2 subtype HA it was reported that acylation does
not inﬂuence HA’s membrane fusion activity, but plays an
essential role for virus particle assembly (Chen et al., 2005;
Zurcher et al., 1994).
Several studies illuminated the essential role of palmitoyla-
tion for association of HA with rafts, cholesterol and sphin-
golipid-enriched nanodomains on the cellular plasma
membrane that serves as the viral assembly and budding site
(Engel et al., 2010; Levental et al., 2010;Melkonian et al., 1999;
Veit and Thaa, 2011) (Fig. 6). Interestingly, HEF is apparently
not a component of rafts, at least it does not associate with
detergent-resistant membranes, their controversial biochemi-
cal correlate indicating that virus particles buds from the bulk
phase of the plasma membrane (Zhang et al., 2000).
PROTEOLYTIC CLEAVAGE OF HEF
After synthesis of the precursor HEF0 a yet unknown protease
hydrolyses the peptide bond between Arg432 and Ile433,
which is located in the stem region of the trimeric spike and
thus in a similar position as the cleavage site in HA (Klenk
et al., 1975; Lazarowitz and Choppin, 1975; Rosenthal et al.,
1998; Sugawara et al., 1981). The resulting subunits HEF1
and HEF2 remain covalently connected by a single disulﬁde
Palmitate (16C) Lipid raft
Cys Cys
FEH C azneulfnIAH B azneulfnIAH A azneulfnI
Stearate (18C)




Figure 6. Different acylation and lipid raft association of HA and HEF protein. HAs of inﬂuenza A virus contain one stearate
attached to a cysteine positioned at the end of the transmembrane region and two palmitates attached to cytoplasmic cysteines. HA
of inﬂuenza B virus possesses two palmitates attached to cytoplasmic cysteines. HEF of inﬂuenza C virus has only one stearate
attached to a transmembrane cysteine. Whereas HA of inﬂuenza A and B virus are associated with membrane rafts, cholesterol- and
sphingolipid-enriched nanodomains of the plasma membrane, HEF is thought to localize to the bulk phase of the plasma membrane.
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linkage, which is also located in the stalk region of the protein.
Proteolytic cleavage is an essential prerequisite for the
membrane fusion activity of HEF (and also of HA) since it
enables the protein to get activated by low pH (Herrler et al.,
1981; Kitame et al., 1982; Ohuchi et al., 1982).
HEF proteins from all inﬂuenza C virus strains contain a
monobasic cleavage site and are in this respect similar to HAs
from human, porcine, equine and low pathogenic avian inﬂu-
enza A viruses (Herrler and Klenk, 1991; Neumann and
Kawaoka, 2006). Polybasic cleavage sites that are present in
HA of highly pathogenic avian inﬂuenza A viruses and pro-
cessed by the ubiquitous protease furin are not found in any
HEF protein. Consequently, replication of inﬂuenza C virus is
limited to thesite of virus infection, the respiratory tract. Spread
to other tissues or even systemic infection, as observed for
highly pathogenic avian inﬂuenza virus having a multibasic
cleavage site between HA1 and HA2, does not occur with
inﬂuenza C virus (Horimoto and Kawaoka, 1994; Stieneke-
Grober et al., 1992). Multiple replication cycles of inﬂuenza C
virus in tissue culture are enabled by addition of trypsin,
whereas embryonated eggs produce infectious virus with
cleaved HEF (Herrler et al., 1979; Sugawara et al., 1981).
The enzyme catalyzing proteolytic cleavage of HEF has not
been identiﬁedso far, but sincebothHAandHEFcanbecleaved
by trypsin at similar concentrations in vitro (5∼20 µg/mL) it
seems likely that they are also activated by the same (or very
similar) enzymes inside cells (Herrler et al., 1979; Nerome et al.,
1979). Likely candidates are members of the family of type II
transmembrane serine proteases, such as HAT (human airway
trypsin-like protease), TMPRSS2 and TMPRSS4 (transmem-
brane protease serine S1, members 2 and 4). These enzymes
are expressed at the plasma membrane of human bronchial/
tracheal epithelial cells where they cleave HA from various, but
not all subtypes (Bottcher-Friebertshauser et al., 2013).
REGULAR ARRANGEMENT OF HEF SPIKES IN
VIRUS PARTICLES
Electron microscopy revealed another unique feature of
inﬂuenza C virus particles not observed for inﬂuenza A and B
virions. HEF trimers on the surfaces of both spherical and
ﬁlamentous particles are arranged in a reticular structure that
has been described to consist mainly of hexagons (Com-
pans et al., 1977; Flewett and Apostolov, 1967; Waterson
et al., 1963). The regular polymeric reticular structure can be
observed not only on the surface of intact viral particles, but
also when HEF is removed from the membrane, either by
limited proteolytic digestion or by spontaneous release
(Herrler et al., 1981). These results indicate (i) that the
hexagonal arrangement is an intrinsic feature of HEF and
does not require other viral proteins such as M1 and (ii) its
formation likely involves lateral interaction between the
ectodomains of HEF; the TMR and cytoplasmic tail are not
required to maintain the structures. Which amino acids form
lateral interactions between HEF trimers and which function
it serves for virus replication has not been investigated. One
might speculate that the formation of a regular arrangement
of HEF trimers on the plasma membrane might induce
membrane curvature, i.e. it acts like an extrinsic coat that
might help to sculpt a virus particle out of the membrane.
However, the lateral arrangement of exclusively hexagons
would result in the formation of a ﬂat structure without any
curvature. Thus, in order to create and cover a spherical
particle, HEF must form a precisely deﬁned arrangement of
pentagons and hexagons.
Virus budding might be reinforced by the matrix protein
M1 that has been shown to form virus-like particles when
expressed in the absence of other viral proteins (Muraki
et al., 2004). M1 might execute a pushing force by
oligomerization at the inner site of the plasma membrane.
How these two assumed activities of HEF and M1 are cou-
pled is not obvious since the cytoplasmic tail of HEF is very
short, only three amino acids, and might thus not be able to
bind to M1 with high afﬁnity.
RECEPTOR BINDING ACTIVITY OF HEF
HA of inﬂuenza A and B virus and HEF of inﬂuenza C virus
use different neuraminic acid derivatives as receptor (Fig. 7).
HEF binds to N-acetyl-9-O-acetylneuraminic acid (9-O-Ac-
Neu5Ac), which can be present on both glycolipids and
glycoproteins to function as viral receptor (Herrler et al.,
1988a; Herrler and Klenk, 1987; Herrler et al., 1987; Rogers
et al., 1986). Likewise, HEF binds to its receptor regardless
of whether 9-O-Ac-Neu5Ac is attached via an α-2,3 or α-2,6
linkage to the following galactosyl residue (Rogers et al.,
1986). In contrast, HA uses terminal N-acetylneuraminic acid
(Neu5Ac) and the glycosidic bond of Neu5Ac inﬂuence the
host speciﬁcity. Avian inﬂuenza viruses usually bind to
Neu5Ac-α2,3-Gal while mammalian inﬂuenza viruses usu-
ally bind to Neu5Ac-α2,6-Gal (Thomas and Noppenberger,
2007; Trebbien et al., 2011). The unique receptor speciﬁcity
of inﬂuenza C virus has been used as an efﬁcient tool to
detect 9-O-Ac-Neu5Ac on the surface of various cells (Martin
et al., 2003; Muchmore and Varki, 1987; Zimmer et al.,
1994).
There is some evidence that the abundance of 9-O-Ac-
Neu5Ac in cultured cells inﬂuences the tropism of inﬂuenza
C virus. Inﬂuenza C virus is usually grown in MDCK I cells,
whereas another subline of Madin-Darby canine kidney cell,
MDCK II cells are (due to insufﬁcient number of receptors)
resistant against virus infection. A mutant of inﬂuenza C virus
with the ability to replicate in MDCK II cells has an amino
acid exchange from threonine to isoleucine at position 270
(see Fig. 4 for the location of Thr270 in the crystal structure
of HEF) that apparently increases the afﬁnity of HEF for its
receptor (Szepanski et al., 1992). Using reverse genetics it
was recently conﬁrmed that the exchange from threonine to
isoleucine is necessary and sufﬁcient to enable inﬂuenza C
virus to grow in MDCK II cells (Crescenzo-Chaigne and van
der Werf, 2007).
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The crystal structure shows that HEF binds to 9-O-Ac-
Neu5Ac in a similar pattern as HA binds to Neu5Ac. The
binding elements consist of an α-helix, a loop and an
extended strand (Fig. 8A). The key residues for binding HEF
to 9-O-Ac-Neu5Ac are shown in Fig. 8B. Tyr127, Thr170,
Gly172, Tyr227 and Arg292 form hydrogen bonds with
hydroxyl-groups of the ligand, and some other residues form
the structural support of the receptor binding site. The HEF
binding site also contains a unique hydrophobic pocket that
accommodates the acetyl methyl group (Rosenthal et al.,
1998).
Some coronaviruses, such as the prototype member
mouse hepatitis virus (MHV) and human and bovine coron-
avirus, contain a hemagglutinin esterase (HE) protein that
also uses 9-O-Ac-Neu5Ac as receptor (Mayr et al., 2008;
Schwegmann-Wessels and Herrler, 2006; Vlasak et al.,
1988). The crystal structure of HE from bovine coronavirus
revealed that the ligand is bound in an opposite orientation
compared to HEF and HA (Zeng et al., 2008) (Fig. 8C).
RECEPTOR HYDROLYSIS (ESTERASE) ACTIVITY
OF HEF
In accordance with its receptor binding speciﬁcity, HEF is an
esterase that cleaves acetyl from the C9 position of terminal
9-O-Ac-Neu5Ac residues to release virus particles from
infected cells (Herrler et al., 1988a; Herrler et al., 1985; Mayr
et al., 2008) (Fig. 7). The esterase activity of HEF belongs to
the class of serine hydrolase, where the −OH group of a
serine residue performs a nucleophilic attack on the car-
bonyl-group of the substrate. Since the −OH group is not
sufﬁciently nucleophilic it is activated by two other amino
acids that together build the typical catalytic triad of serine
hydrolases, the amino acids serine, histidine and aspartic
acid. The base histidine polarizes and deprotonates the
−OH-group of serine to increase its reactivity whereas
aspartic acid aligns and polarizes the histidine (charge relay
system) (Herrler et al., 1988b; Kraut, 1977; Pleschka et al.,
1995).
Crystallography in the presence of two non-hydrolysable
receptor analogues of HEF revealed that serine 57, aspartic
acid 352 and histidine 355 are the key residues for the
acetylesterase activity of HEF (Rosenthal et al., 1998)
(Fig. 8D). Prior to that it has already been shown that
mutation of Ser57 and His355 completely abolished the
enzymatic activity of HEF, essentially conﬁrming the data
from crystallography, but mutation of other residues in the
vicinity, i.e. Asp247, Asn266 and His354 also affected the
hydrolytic activity of HEF (Pleschka et al., 1995).
Ser57 is positioned for nucleophilic attack on the carbonyl
carbon of the 9-O-Ac-Neu5Ac group. The carbonyl oxygen of















Influenza C receptor  
9-O-acetyl-sialic acid 
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NA neuraminidase activity
Figure 7. Cellular receptors and receptor-destroying activity of inﬂuenza C virus and inﬂuenza A and B virus. The structure of
cellular receptors for HEF from inﬂuenza C virus (N-acetyl-9-O-acetylneuraminic acid) and HA from inﬂuenza A and B virus (N-
acetylneuraminic acid) are shown. Both neuraminic acid derivatives are the terminal sugars in carbohydrate chains attached to
glycolipids or glycoproteins located at the cellular surface. Subtypes of inﬂuenza A virus HA discriminate between an α2-6 and α2-3
linkage to the second galactosyl residue, a property that (partially) explains species speciﬁcity. HEF of inﬂuenza C virus apparently
recognizes N-acetyl-9-O-acetylneuraminic acid independent of its linkage to the next sugar. HEF has also esterase activity that
cleaves acetyl from the C9 position. In inﬂuenza A and B virus the receptor-destroying activity is performed by the NA protein, which
hydrolyzes the glycosidic bond between sialic acid and galactosyl residues. The cleaved bonds are indicated by a red line.
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side chain of Asn117 and the NH -groups of Gly85 and
Ser57 (Rosenthal et al., 1998). Arg 322 of HEF forms two
hydrogen bonds with the sialoside carboxylate group
(Fig. 8D). The structure of the esterase site is quite similar
between HEF and coronavirus HE. The catalytic triad of HE
consists of the same amino acids, i.e. Ser40, His329 and
Asp326; Ser40 also forms an oxyanion hole with the side
chains of Gly75 and the NH group of Asn104 (Zeng et al.,
2008).
MEMBRANE FUSION ACTIVITY OF HEF
Membrane fusion between the viral envelope and endocytic
vesicles is the crucial step to release the viral genome into
the cytoplasm of the cell (Hamilton et al., 2012; Skehel and
Wiley, 2000). There are two essential requirements for both
HEF and HA to catalyze membrane fusion: (i) The precursor
proteins HEF0 and HA0, must be cleaved into the subunits
HEF1 (HA1) and HEF2 (HA2). (ii) The proteins must then be
exposed to acidic pH to become fusogenic. This was initially
demonstrated for inﬂuenza viruses by a simple membrane
fusion assay, hemolysis of erythrocytes that occurs only if
virus particles containing cleaved HA or HEF are exposed to
acidic pH (Formanowski et al., 1990; Huang et al., 1981;
Kitame et al., 1982; Lenard and Miller, 1981; Maeda and
Ohnishi, 1980; Ohuchi et al., 1982). Biochemical assays
subsequently revealed that low pH initiates a conformational


































Figure 8. Structures of receptor binding site and esterase site of HEF, HA and HE. (A) Superimposing of HEF and HA receptor
binding sites complexed with ligand (9-acetamidosialicacid α-methyl glycoside). The yellow-green lines and the light blue lines
represent the binding elements of HA and HEF, respectively. (B) Structure of HEF binding sites complexed with the receptor. Key
residues forming hydrogen bonds with the ligand are shown. (C) Comparison of the receptor binding topology of the hemagglutinin-
esterase (HE) protein of coronavirus, HEF and HA with their ligands. The bound ligands are αNeu4,5,9Ac32Me in HE,
αNeu5,9Ac22Me in HEF and αNeu5Ac2Me in HA are shown in stick representation. The ligand is bound to HE in an opposite
orientation compared to HEF and HA. (D) Structure of the esterase active site of HEF. Key residues forming hydrogen bonds with the
ligand are shown. (A), (B) and (D) were taken from reference (Rosenthal et al., 1998) and (C) from reference (Zeng et al., 2008) with
permission.
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digestion (Formanowski et al., 1990). The low pH is thought
to cause protonation of speciﬁc amino acids that triggers the
following large scale rearrangement of the proteins. Histidi-
nes might play this role since their pKas match the pH of
endosomes (5.5–6). For HA of inﬂuenza A virus speciﬁc
histidine residues have been identiﬁed (Mair et al., 2014), but
similar studies have not been performed with HEF. In both
inﬂuenza A and C virus threshold pH values that initiate
membrane fusion differ from strain to strain by about 0.7 pH
units. This does not necessarily mean that different histidi-
nes are the relevant target of protonation, but that (between
strains) variable amino acids in the vicinity of a speciﬁc
histidine affect its pKa. For inﬂuenza C virus pH values
required to cause hemifusion (measured as lipid mixing,
range of 5.6–6.1) are 0.3–0.6 pH units higher than pH values
for full fusion (measured by hemolysis, range of 5.1–5.7)
(Formanowski et al., 1990).
Interestingly, kinetic studies with inﬂuenza C virus
revealed a lag phase before onset of fusion that is not
observed with inﬂuenza A and B virus (Formanowski et al.,
1990). It is likely that the lag phase reﬂects dispersion of
the lateral arrangement of HEF spikes on the viral mem-
brane that might hinder HEF’s conformational change.
Accordingly, when virus particles are treated with low pH
before electron microscopy, HEF spikes are less well
ordered and the typical hexagonal structure disappeared
(Hewat et al., 1984).
The molecular details of the subsequent refolding of HEF
have not been revealed, but it is believed that they are
similar to the well characterized conformational changes of
HA that were elucidated by a comparison of the crystal
structure of HA at neutral pH with the structure of a HA
fragment after low pH treatment (Bullough et al., 1994). The
ﬁrst conformational change removes the fusion peptide from
its buried location at the bottom of the stalk and exposes it at
the surface of the molecule such that it can insert into the
endosomal membrane (“jackknife mechanism”). A second
conformational change then bends the ectodomain thereby
drawing the fusion peptide towards the transmembrane
region. This leads to a close apposition of viral and endo-
somal membranes, hemifusion with exchange of lipids,
opening of a fusion pore and eventually complete merger of
both lipid bilayers. The second conformational change
requires so-called “heptad repeats”, amphipathic helices
which interact to form a stable 6-helix coiled coil domain
(Cross et al., 2009; Harrison, 2008; Kemble et al., 1994;
Skehel and Wiley, 2000) (Fig. 9A and 9B). With the software
“Multicoil Scoring Form” (http://groups.csail.mit.edu/cb/
multicoil/cgi-bin/multicoil.cgi), a highly probable heptad
repeats domain was found between amino acids 500 and
540, residues that encompass the long α-helix of HEF2.
They are thus in a similar position as the heptad repeats that
form the six-helix bundle coiled-coil in the low pH structure of
HA (Fig. 9C). This region of HEF thus might convert from a
long, uninterrupted helix into two smaller, antiparallel helices,
which are connected by a loop and form the coiled-coil
domain that stabilizes the fusion conformation (Bullough
et al., 1994) (Fig. 9A and 9B).
The fusion peptides of HA and HEF have similar, but also
different features. The ﬁrst 23 amino acids of HA2
(GLFGAIAGFIEGGWTGMIDGWYG, sequence of H1 sub-
type) is highly conserved between subtypes and contains
hydrophobic, aromatic, but also some negatively charged
residues. It is also characterized by GxxG and GxxxG motifs
that are known to mediate interactions between transmem-
brane segments. In a lipid environment the fusion peptide of
HA forms a boomerang-like structure (aa 1–20) or a (tighter)
helical hairpin (aa 1–23) (Han et al., 2001; Lorieau et al.,
2012). The sequence at the N-terminus of HEF2 (IFGID-
DLIIGLLFVAIVEAGIGG) is not conserved to that of HA2.
However, if the ﬁrst six residues, which are not buried within
the trimeric stalk, are not taken into account some sequence
homology between HA and HEF is apparent. The fusion
peptide of HEF has a similar amino acid composition as that
of HA, but glycine residues do not form GxxG or GxxxG
motifs. The structure of HEF’s fusion peptide in lipid micelles
is not known, but in the HEF trimer it already adopts a loop-
like structure.
WHY STUDY INFLUENZA C VIRUS?
Although inﬂuenza C virus is currently not a serious threat to
humans, it might be nevertheless fruitful and revealing to
study its biology. Whereas the receptor-binding and recep-
tor-destroying activities of HEF are now well characterized
and its fusion activity is likely to be similar to that of HA, the
mechanism of virus assembly and budding is largely unex-
plored and might be different for inﬂuenza A and C virus. If it
is conﬁrmed by more sophisticated methods that HEF does
not associate with membrane rafts (Zhang et al., 2000), it is
likely that inﬂuenza A and C virus bud at different sites of the
apical plasma membrane, membrane rafts in the case of
inﬂuenza A virus (Gerl et al., 2012; Rossman and Lamb,
2011) and the bulk phase or other domains in the case of
inﬂuenza C virus. Since rafts are believed to enrich viral
proteins and deplete many cellular proteins they represent
the ﬁrst concentration step in the assembly of a virus particle
that contains very little cellular proteins (Veit and Thaa,
2011). One might speculate that the regular arrangement of
HEF trimers might substitute for the concentration of HA in
rafts, i.e. its formation might displace cellular proteins from
the viral assembly site. A regular arrangement of hexagons
and pentagons might then help to shape a virus particle out
of the plasma membrane.
For inﬂuenza A virus it has been demonstrated that virus
scission is achieved by the M2 protein that is targeted to the
edge of the assembly site and inserts an amphiphilic helix
into the inner leaﬂet to induce membrane curvature (Ross-
man et al., 2010). Whether CM2 plays a similar role for
release of inﬂuenza C virus has not been investigated, but
the bioinformatic tool heliquest (http://heliquest.ipmc.cnrs.fr/)
predicts the presence of an amphiphilic helix at the
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beginning of the cytoplasmic tail of CM2. The recent devel-
opments of reverse genetics systems for inﬂuenza C virus
make some of the mentioned questions amenable to
experimental veriﬁcation (Crescenzo-Chaigne and van der
Werf, 2007; Muraki et al., 2007; Pachler et al., 2010). Thus,
further studies might reveal common and different principles
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Figure 9. Probable mechanism for HEF-mediated membrane fusion. (A) Probable conformational change of HEF2 during
membrane fusion. Left part: structure of the HEF2 subunit at neutral pH. The HR is located in the long α-helix of HEF2 and thus in a
similar position as the HR in HA. Right part: hypothetical structure of the HEF2 subunit at acidic pH. (B) Hypothetical scheme for the
HEF-catalyzed membrane fusion mechanism. Upper left part: HEF binds to its receptor via its HEF1 subunit (brown) and is
endocytosed. Upper right part: Acidiﬁcation of the endosome causes a conformational shift in HEF2. The fusion peptide, which was
(partially) buried in the stalk is exposed and inserts into the endosomal membrane. Lower, left part: The middle part of the HR domain
(green) changes its conformation from a helix to a loop, which causes bending of the molecule and close apposition of viral and cellular
membrane allowing the exchange of lipids (hemifusion). Lower, right part: Interactions between the fusion peptide and the TMD of HEF
might cause opening of a fusion pore. (C) Prediction of a heptad repeat (HR) in HEF by online software “multicoils scoring form”.
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